Kerry Wentworth
Vermogen: 253 340 $ op 31-05-2026
Vermogen: 253 340 $ op 31-05-2026
Ms. Kerry A. Wentworth is a Chief Regulatory Officer at Nuvation Bio, Inc. She is on the Board of Directors at Massachusetts Biotechnology Council.
Ms. Wentworth was previously employed as a Chief Regulatory Officer by Flexion Therapeutics, Inc., a Vice President-Clinical, Regulatory & Quality by Agenus, Inc., a Senior Director-Regulatory Affairs by Genelabs Technologies, Inc., and a Head-Regulatory Affairs by Genzyme Corp.
She received her undergraduate degree from the University of New Hampshire.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-04-2026 | 53.000 ( 0,02% ) | 253 340 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUVATION BIO INC. | Algemeen Adviseur | 18-07-2022 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Bestuurslid | 01-04-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Algemeen Adviseur | 19-11-2021 |
| AGENUS INC. | Hoofd Techniek/Wetenschap/O&O | 10-07-2014 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Algemeen Adviseur | - |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Nuvation Bio, Inc.
Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau